An Indian pharmaceutical innovator, C&D Pharma has introduced three new novel treatments for Non-Communicable Diseases on the Ugandan market.
The three fourth generation therapies include Cliniplan Trio, Dairetin Family and Daptide were introduced onto the Ugandan market.
Cliniplan Trio is an antihypertensive combination therapy that effectively manages high blood pressure while protecting vital organs such as the heart, kidneys, brain, and eyes, while Dairetin Family which also includes Diatrin M and Diatrin Trio represents a pioneering advancement in diabetic care, offering stable blood sugar control and reducing the risk of diabetes-related complications.
Daptide is meant to revolutionize chronic disease management as it targets diabetes and hypertension, offering precise control that mitigates complications affecting the heart, kidneys, and blood vessels.
Speaking during the function to unveil the three fourth generation therapies, Dr.Charles Olaro, the Director of Curative Services at the Ministry of Health said Non-communicable diseases like hypertension, diabetes, and cardiovascular disease have a significant impact on Ugandan families and communities.
“The burden of these diseases, especially in rural and underserved areas, calls for innovative solutions. We need treatments that manage symptoms and prevent long-term complications that strain our healthcare resources,” Dr.Olaro said.
He said the introduction of the three fourth-generation therapies will help advancing the country’s ability to treat these conditions more effectively .
“ These medications not only improve the lives of patients but also help alleviate the pill burden on patients and cost families struggling to treat prolonged in our healthcare facilities. We are taking an essential step towards health equity by ensuring that these medications reach even the most remote communities.”
He said the Ministry of Health is committed to support such initiatives aimed at promoting health and well-being across the country.
The Managing Director, C&D Pharma Chirag Vora said through the three new therapies, they seek to provide the country with powerful new tools to tackle complex diseases like hypertension, diabetes, and cardiovascular conditions.
“These treatments go beyond managing symptoms; they aim to transform lives by reducing complications and supporting long-term health. We firmly believe that these products, combined with the invaluable support of our partners, will create real, lasting change. Together, we are paving the way for a healthier Uganda, where access to advanced medical care is a right, not a privilege, ”Chirag said.
Officials said the rural and underserved populations will be reached through partnership with Joint Medical Stores and KAMCARE.
